The protein expression levels of GBP5 in the tumor tissues exceeded that in CTAN from a total of 499 OSCC patients including 182 BMSCC, 245 TSCC, and 72 LSCC patients (Figure 1D, Table 1, Figure S1B). This evidence concerns the gene GBP5 and neoplasm.